4.8 Article

Transforming Growth Factor-β3 Regulates Adipocyte Number in Subcutaneous White Adipose Tissue

期刊

CELL REPORTS
卷 25, 期 3, 页码 551-+

出版社

CELL PRESS
DOI: 10.1016/j.celrep.2018.09.069

关键词

-

资金

  1. Swedish Research Council
  2. Novo Nordisk Foundation [NNF15CC0018486, NNF15SA0018346]
  3. CIMED
  4. European Association on the Study of Diabetes
  5. Eli Lilly
  6. Swedish Diabetes Foundation
  7. Stockholm County Council
  8. Diabetes Wellness Fund
  9. Strategic Research Program in Diabetes at Karolinska Institutet
  10. Wenner-Gren Foundation
  11. Marie Sklodowska-Curie Actions
  12. MRC [MC_UU_12012/2, MC_UU_00014/2, G0400192, G0600717, MC_UU_00014/5] Funding Source: UKRI

向作者/读者索取更多资源

White adipose tissue (WAT) mass is determined by adipocyte size and number. While adipocytes are continuously turned over, the mechanisms controlling fat cell number in WAT upon weight changes are unclear. Herein, prospective studies of human subcutaneous WAT demonstrate that weight gain increases both adipocyte size and number, but the latter remains unaltered after weight loss. Transcriptome analyses associate changes in adipocyte number with the expression of 79 genes. This gene set is enriched for growth factors, out of which one, transforming growth factor-beta 3 (TGF beta 3), stimulates adipocyte progenitor proliferation, resulting in a higher number of cells undergoing differentiation in vitro. The relevance of these observations was corroborated in vivo where Tgfb3(+/-) mice, in comparison with wild-type littermates, display lower subcutaneous adipocyte progenitor proliferation, WAT hypertrophy, and glucose intolerance. TGF-beta 3 is therefore a regulator of subcutaneous adipocyte number and may link WAT morphology to glucose metabolism.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据